Both in Pharmaceuticals
MoonLake Immunotherapeutics vs Rigel Pharmaceuticals Inc. (New)
Over the past year MLTX returned +15.5% and RIGL returned +67.4%; their daily moves had a correlation of 0.15.
MLTX +15.5% RIGL +67.4%Growth of $1, one year, split-adjusted
| Metric | MLTX | RIGL |
|---|---|---|
| Price | $11.78 | $51.31 |
| Market cap | $1.00B | $958.5M |
| Today | −6.28% | −0.27% |
| 1 month | +2.7% | +9.2% |
| 6 months | −29.6% | +74.5% |
| Year to date | −10.6% | +19.8% |
| 1 year | +22.6% | +74.5% |
| Revenue growth (YoY) | — | −22.6% |
| Gross margin | — | 89.2% |
| Net margin | — | 22.0% |
| P/E (TTM) | — | 3.0× |
| Price / sales | — | 3.5× |
| Net cash | $437.5M | $56.1M |
| Dividend yield | — | — |
| Volatility (60d) | 58.0% | 36.5% |
| Short % of float | 14.3% | 16.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).